Canopy Growth Corporation develops and sells cannabis products for adult-use and medical markets, with common shares trading as CGC on Nasdaq and WEED on the TSX. Company updates frequently cover Canadian brand activity across Tweed, Deelish, 7ACRES, DOJA, Deep Space and related formats including flower, pre-rolls, vapes, softgels and minor cannabinoid products.
News also centers on medical cannabis services through Canada House Clinics and the Abba Medix online channel, Storz & Bickel vaporization devices, operating and financial results, capital-structure actions, shareholder voting matters and governance changes. Canopy Growth also discloses its unconsolidated, non-controlling interest in Canopy USA as exposure to the U.S. THC market.
Canopy Growth (TSX: WEED, NASDAQ: CGC) has appointed Luc Mongeau as its new CEO, effective January 6, 2025. Mongeau, a current Board member with over 25 years of CPG experience, will succeed David Klein, who announced his planned retirement in August 2024. Mongeau has been involved with the company's board since early 2023, contributing to strategic decisions focused on asset-light expansion and near-term profitability. He previously served as CEO of a leading e-commerce furniture provider and held president roles at Weston Foods and Mars Petcare North America. Klein will transition to a special advisor role until August 31, 2025.
STORZ & BICKEL, a subsidiary of Canopy Growth (TSX: WEED) (NASDAQ: CGC), has won a Gold Medal at the 2024 MarCom Awards for Outstanding Special Event, recognizing their VENTY launch parties. The award celebrates the brand's coast-to-coast product launch events held at Astor Club speakeasies in New York City and Los Angeles. The exclusive events featured product demonstrations by founder Jürgen Bickel, German cuisine, and interactive activities, attracting industry leaders, influencers, and major media outlets including Fast Company, PEOPLE, and Variety.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has announced the launch of Claybourne's Frosted Flyers Infused Pre-Rolls in Canada through an exclusive licensing agreement. The product will be available in five varieties: Blue Dream, Strawberry Cough, Pineapple Express, Grape Gasolina, and Banana OG, featuring 42-48% THC content. The launch targets the rapidly growing pre-roll market in Canada, which has grown 94% since 2022, with infused pre-rolls representing 9.6% of the total recreational market. The products feature diamond frosting, liquid diamond infusion, terpene enhancement, and premium indoor full nug flower.
Canopy Growth (TSX: WEED, Nasdaq: CGC) reported Q2 FY2025 financial results with mixed performance. Net revenue decreased 9% year-over-year to $63.0MM, though excluding divested businesses, it grew 3%. Storz & Bickel showed strong growth with revenue up 32% to $16MM. Medical cannabis revenue increased in both Canada (16%) and international markets (12%). The company reduced its Adjusted EBITDA loss by 54% to $6MM and improved free cash flow by 16%. Gross margin increased to 35%, up 100 basis points from last year. The cash position strengthened to $231MM, up from $195MM in the previous quarter.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has announced it will release its second quarter fiscal 2025 financial results before market open on November 8, 2024. The results will cover the period ended September 30, 2024. Following the release, the company will host an audio webcast at 10 AM Eastern Time featuring CEO David Klein and CFO Judy Hong. The webcast will be available live and accessible for replay until February 6, 2025.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has made an early prepayment of US$100 million on its senior secured term loan at a discounted price of US$97.5 million. This move will result in annualized interest expense savings of approximately US$14 million and extends the loan's maturity date to December 18, 2026. The company has the option to make an additional US$100 million prepayment by March 31, 2025, which would further extend the maturity to September 18, 2027.
This action is part of Canopy Growth's strategy to reduce leverage, improve its balance sheet, and demonstrate fiscal discipline. CFO Judy Hong stated that this prepayment reflects the company's commitment to reducing cash burn and strengthening its capital structure, enabling investment in growth areas and long-term value creation for shareholders.
Canopy Growth (TSX: WEED, NASDAQ: CGC) has confirmed that Canopy USA has completed its acquisition of Wana, including Wana Wellness, The CIMA Group, and Mountain High Products. This follows Canopy USA's acquisition of approximately 75% of Jetty shares in June 2024. The move aligns with Canopy USA's strategy to establish a leading brand-focused cannabis company in the U.S.
Wana recently launched Wanderous™, a direct-to-consumer marketplace offering hemp-derived products, including Delta-9-THC and CBD gummies from various brands. Wana also introduced a new line of infused sparkling beverages. The acquisition is expected to unlock new growth opportunities in state-legal markets and through hemp-derived products across the U.S.
Canopy USA anticipates realizing significant financial benefits, including revenue growth and cost synergies, from the acquisitions of Wana, Jetty, and the contemplated acquisition of Acreage Holdings.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) announced the voting results from its annual general meeting held on September 24, 2024. All matters put forward for shareholder consideration were approved. The election of directors saw all nominees elected with votes FOR ranging from 87.26% to 89.23%. Shareholders also approved the appointment of PKF O'Connor Davies, LLP as auditors for the fiscal year ending March 31, 2025, and authorized the board to fix their remuneration. Additionally, an advisory resolution on executive compensation was approved. Detailed voting results will be available on SEDAR+ and EDGAR.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has extended the proxy voting deadline for its upcoming annual general meeting to September 24, 2024 at 9:00 a.m. (Eastern Time). The meeting will be held virtually at 1:00 p.m. the same day. This extension aims to ensure a quorum of 33 1/3% of outstanding shares is achieved, as required by NASDAQ listing rules.
CEO David Klein emphasized the importance of shareholder participation to reach quorum. The company has retained Laurel Hill Advisory Group and Alliance Advisors as proxy solicitors to assist shareholders with voting. Shareholders can vote online, by phone, or by mail, depending on how they hold their shares.
The company urges all shareholders to vote, highlighting the ease and importance of the process. Detailed voting instructions and contact information for assistance are provided in the press release.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) is urging shareholders to vote before the September 20, 2024 deadline for the upcoming annual general meeting on September 24, 2024. The company emphasizes the importance of achieving a 33 1/3% quorum, which is required for Nasdaq-listed companies. Canopy Growth has released a Q&A to address common shareholder questions about voting and quorum importance. The Board recommends voting FOR each proposal. Shareholders can vote online, by phone, or mail, with assistance available from Laurel Hill Advisory Group. The company stresses that every vote counts, especially given its diverse shareholder base without significant block holders.